NASDAQ · Stocky rates: Cautious

DFTX

$46.14 ▲ +3.94% as of 6 Aug, 20:00

Stocky turns companies like DFTX into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.

Try Stocky free →
40
/ 100
Neutral

What Stocky thinks

Cautious. Defterra's pipeline hinges entirely on Phase 3 success for DT120 in anxiety and depression—trials just initiated in late 2024/early 2025—making regulatory execution the dominant risk. With a 55/100 Leadership Alignment score and modest value fundamentals (24/100), the company lacks margin-of-safety moats to absorb clinical setbacks.

Compounder Score
24/100
Business quality — profitability, growth, capital efficiency.
Leadership Alignment
55/100
Founder-led, insider ownership, capital allocation history.
Vulnerability
75/100
Downside resilience — customer concentration, supply chain, refinancing risk.
Value Score
24/100
Valuation vs peers and history — is this a good price to pay?

What Stocky gives investors that other tools don't

Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for DFTX:

40
VERDICT

Stocky Verdict — one score, everything

Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 40/100, you know instantly whether to dig deeper or skip.

Rated
MOAT

Moat Score — is there a real edge?

Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.

55
LEADER

Leadership Alignment — is management on your side?

Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.

75
RISK

Vulnerability Profile — what could break?

Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.

Elite
TRACK

Track Record — does the system work?

Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.

24/7
ALERTS

Alerts + Portfolio insights

Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.

DFTX (DFTX) — frequently asked

Is DFTX (DFTX) a good investment right now?

Stocky rates DFTX (DFTX) at 40/100 — below the bar Stocky looks for. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Cautious. Defterra's pipeline hinges entirely on Phase 3 success for DT120 in anxiety and depression—trials just initiated in late 2024/early 2025—making regulatory execution the dominant risk. With a 55/100 Leadership Alignment score a

What is DFTX's Stocky Verdict?

DFTX's current Stocky Verdict is 40/100, placing it in the "Cautious" band. This composite combines a 24/100 Compounder score, 55/100 Leadership, Moat rating, and analyst signal.

Does DFTX have a competitive moat?

Stocky hasn't finalised a Moat Score for DFTX yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.

Is DFTX's leadership aligned with shareholders?

DFTX scores 55/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.

What are the biggest risks to DFTX?

DFTX's Vulnerability Profile scores 75/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to DFTX.

This is just the surface. See the whole picture on DFTX.

Sign up free and unlock the full analysis on DFTX — the same tools professional analysts use, personalised to your portfolio:

  • Every analyst covering DFTX — full list with star ratings, price targets, historical hit-rate. Not just the top 3 you see above.
  • Full Vulnerability Profile — customer concentration, refinancing walls, stress-test scenarios (-20% revenue, +200bp rates) modelled specifically for DFTX.
  • Bull & bear thesis — the AI-written counter-argument every retail investor forgets to read.
  • Portfolio fit check — how DFTX changes your sector concentration, correlation and Verdict-weighted quality.
  • Ask Stocky AI — "What are the biggest 3-year risks to DFTX?" · "Is DFTX overvalued vs its 5-year median?" · unlimited follow-ups on your portfolio.
  • Live alerts — analyst target changes, insider buys, big moves — the day they happen.
Start free · 14 days Plus, no card →

Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.

STOCKY VERDICT
40
/ 100 · Neutral

See DFTX the Stocky way

This page is just a preview. Open the live, interactive version for the full picture:

Stocky Verdict
A plain-English Buy / Hold / Sell score out of 100.
Compounder & Value scores
How strong the business is — and whether it looks cheap.
Interactive charts
1M to 5Y price history with company events plotted on it.
Top analyst targets
What the best-rated Wall Street analysts expect next.
What if? simulator
See what an investment in DFTX would be worth today.
Practice portfolio
Buy DFTX with virtual money and track it — zero risk.
Free · no real money · learn by doing Open DFTX in Stocky →

Or jump straight to the interactive dashboard for DFTX in the app.